Skip to content
healthcare.dev
Get a free key

Darunavir 600 and 800 mg

NDC 69097-248, darunavir, tablet, from Cipla USA Inc..

Product NDC
69097-248
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206288
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-248 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARUNAVIR HYDRATE600 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]

Package NDCNDC-11Package
69097-248-036909702480360 TABLET in 1 BOTTLE (69097-248-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5624cc30-d484-458e-b234-9bb745a118ca

  • NADAC price for package 69097024803

    GET /v1/drugs/nadac/69097024803

Use it

Look up 69097-248 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-248 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-248. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.